By Dr Shane Oliver, Chief Economist and Head of Investment Strategy at AMP. Investment markets and key developments US and ...

India and the US are key trade partners, but a formal trade deal is still missing. As talks progress, the big question is: ...

Japanese SMEs like Mitsuwa Electric, a specialized manufacturer, are cautiously optimistic about weathering potential US ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Tariffs and the uncertainty surrounding them emerged as the biggest policy issue coming out of the first six months of the new administration.

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...

President Donald Trump says he plans to place tariffs of over 10% on smaller countries, including nations in Africa and the ...

Healthcare delivery organizations are saying they have yet to fully recover financially from the COVID-19 pandemic, and a high level of uncertainty around changing regulations and economic conditions ...

Healthcare costs are already expensive for many. In some states, tariff-related price hikes are showing up in 2026 rate ...